Comprehensive assessment of metabolic syndrome among rural Bangladeshi women by Jesmin, Subrina et al.
RESEARCH ARTICLE Open Access
Comprehensive assessment of metabolic
syndrome among rural Bangladeshi women
Subrina Jesmin
1,2*, Md Reazul Islam
1,2, A M Shahidul Islam
1,2, Md Sohag Mia
1,2, Sayeeda Nusrat Sultana
1,2,
Sohel Zaedi
1,2,3, Naoto Yamaguchi
3, Yoshio Iwashima
4, Michiaki Hiroe
1 and Tetsu Watanabe
5
Abstract
Background: Metabolic syndrome (MS), defined as a constellation of cardiovascular disease (CVD) risk factors, is
one of the fastest growing public health burdens in the Asia-Pacific region. This trend is despite the fact that
people in this region are no more overweight than Europeans and Americans. Unfortunately, in South Asia, MS
screening has only been performed in a few countries other than Bangladesh. Therefore the present study is
designed to conduct a comprehensive screening of MS in Bangladeshi rural women, which includes estimation of
prevalence and assessment of risk factor.
Methods: A total of 1535 rural Bangladesh women aged ≥ 15 years were studied using a population based cross-
sectional survey. The prevalence of MS was estimated using NCEP ATP III, modified NCEP ATP III and IDF criteria.
Results: The prevalence rates of MS were 25.60% (NCEP ATP III), 36.68% (modified NCEP ATP III), and 19.80% (IDF),
as revealed by the present study. Furthermore, based on the NCEP ATP III criteria, 11.60% of the subjects were
found to have excess waist circumference; 29.12% had elevated blood pressure, 30.42% had elevated fasting
plasma glucose level, 85.47% had low HDL values and 26.91% had increased triglyceride values. Low plasma HDL
level was found to be the most common abnormality in the target population and elevated waist circumference
was the least frequent component.
Conclusions: The present study reveals a high prevalence of MS and its associated risk factors in rural Bangladeshi
women. These findings are important in that they provide insights that will be helpful in formulating effective
public health policy, notably the development of future health prevention strategies in Bangladesh.
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Background
Metabolic syndrome (MS) is described as a cluster of
abnormalities that confers an increased risk of develop-
ing atherosclerotic cardiovascular diseases (CVD) and
also type 2 diabetes mellitus (T2DM). In fact, MS is
now considered as a global epidemic [1], with current
estimates about 20-30% of the adult population world-
wide is affected [2]. Of interest to the current study is
the fact that the prevalence of these disorders (MS and
CVD) among South Asians [3], a community that repre-
sents one-fifth of the global population [4], is on the
rise. This development imposes a significant health
burden to the subcontinent that has limited resources.
The exact cause of this health trend is currently not
clear. Nonetheless, several factors are believed to be
potential etiological factors in the development of MS,
including increased urbanization, economic growth, irre-
gular meal times, and lifestyle change and adoption of
western diet [5]. Unfortunately, millions of people in
South Asia are facing a double health burden [2] i.e., the
impact of poverty-related diseases (associated with infec-
tions and nutrition) is being exacerbated by the increas-
ing load of chronic non-communicable diseases [6]. To
date there has been very few studies conducted on rural
women in Bangladesh. Because of our earlier prelimin-
ary data on this population were alarming, we decided
to undertake a more detailed study to investigate the
metabolic syndrome in rural Bangladeshi population,
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higher prevalence of diabetes among Bangladeshi
women, surprisingly, even in those living in rural
regions [7].
T h ep u r p o s eo ft h ep r e s e n ts t u d yw a s ;t h e r e f o r e ,t o
evaluate the prevalence of MS, identify the set of signa-
ture risk factors of MS and CVD that are unique to
South Asia. Further we will examine the correlation of
MS and CVD to the socio-economic and environmental
conditions, particularly in Bangladesh rural women.
Methods
Participants
In a community based cross-sectional study of rural
women, a total of 1535 participants aged ≥ 15 years
were selected using stratified multistage random sam-
pling. This sample size was sufficient enough to test the
research hypothesis at 5% level of significance with a
statistical power of 90% (b = 0.90). The study uses the
World Health Organization’s STEPS approach (modi-
fied), which entails a stepwise collection of the risk fac-
tor data based on standardized questionnaires covering
demographic characteristics, somatic illnesses, somatic
and mental symptoms, medications, life style, and
health-related behavior (step 1), basic physical measures
(step 2) and basic biochemical investigations, such as
levels of blood glucose and cholesterol (step 3). All par-
ticipants gave informed consent.
The study was carried out in six village communities
in Gabindagonj upazila (sub-district) of Gaibandha dis-
trict. This is a district in Northern Bangladesh (currently
in Rangpur division, the poorest region of the country,
Bangladesh); the respondents were selected randomly
after selecting the division, district, and villages. Gai-
bandha district was established in 1984. The district
consists of 7 upazilas, 3 municipalities, 27 wards, 82
union parishads, 1101 mouzas, 56 mahallas and 1244
villages. 7 upazilas/thanas are Fulchhari, Gaibandhasa-
dar, Gobindaganj, Palashbari, Sadullapur, Saghata, and
Sundarganj. The three municipalities are Gaibandha
Sadar, Gobindaganj and Sundarganj.
The demographic profiles of the communities are
(year 2003): 2,117,959, i.e., males 50.26% and females
49.74%. Average literacy 24.3%, i.e., male 31.6% and
female 16.5%. Women were recruited through local
announcements (loudspeaker) at community level and
by house-to-house visits. After recruitment, participants
were interviewed and examined clinically at mobile
examination center and their blood samples were
collected.
Furthermore, the socio-demographic-economic status
and physical activity of the participants was assessed
using standard methods. Participants with the following
conditions were excluded from the study: pregnancy,
any acute illness, on steroidal medications or any other
medications likely to cause elevated plasma glucose, suf-
fering from chronic renal or pancreatic diseases, on hor-
mone replacement therapy (HRT) as well as individuals
with known illness like ischemic heart disease (IHD),
diabetes, and hypertension, and individuals who have
lived in Gabindagonj for less than 6 months.
The study was approved by the Ethical Committee of
the Health and Disease Research Center of Rural Peo-
ples (HDRCRP), Dhaka, Bangladesh. This study con-
formed to the principles outlined in the Helsinki
Declaration, and all subjects gave their written informed
consent before inclusion in the study.
Anthropometry
The following parameters were measured thrice and the
mean was then determined: height (cm), weight (kg)
and waist circumference (cm). For measuring height,
subjects were requested to stand upright on a stadi-
ometer, with their back against the wall, eyes directed
forward, without shoes and with their heels aligned
together. Weight was measured to the nearest 100 g
using a digital weighing machine that was kept on a
firm flat surface and checked with ‘known’ weights every
day. Waist circumference was measured with a non-
stretchable tape at the midpoint between the lower bor-
der of the rib cage and upper border of the iliac crest.
Blood pressure (BP) was measured using the standard
mercury manometer and cuff, twice in the right arm in
a sitting position, to the nearest 2 mmHg, with the
initial reading taken at least 5 min after the subject was
made comfortable, and again after an interval of 15 min.
The average systolic and diastolic blood pressure were
then determined.
Biochemical analysis
Blood for biochemical analysis was obtained from the
participants after 10-12 h of an overnight fast. The
serum was immediately separated by centrifugation,
and the concentration of triglycerides (TG) [lipopro-
tein lipase method; Wako Chemicals, Tokyo, Japan],
total cholesterol (TC) [Cholesterol E, Wako Pure Che-
mical Industries, Ltd. Osaka, Japan]and its fractions
[low-density lipoproteins (LDL)] and high-density lipo-
proteins (HDL) [high density lipoprotein (HDL)-cho-
lesterol with the Determiner-L kit (Kyowa Co Ltd,
Tokyo, Japan)] were ascertained. Fasting plasma glu-
cose [glucose with the Hexokinase G-6-PDH kit
(Wako Pure Chemical Industries Ltd, Osaka, Japan)]
and insulin were also measured. LDL-cholesterol was
calculated as total cholesterol–HDL-cholesterol–
VLDL-cholesterol; VLDL-cholesterol was calculated as
0.456 × total triglyceride concentration expressed in
mmol/L (Friedewald).
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The major components of MS include central obesity,
elevated BP, dyslipidemia and impaired glucose metabo-
lism or insulin resistance. According to the NCEP ATP
III definition, MS is diagnosed when 3 or more of the
following 5 components are present: (1) elevated waist
circumference (WC ≥ 88 cm in women), (2) elevated tri-
glyceride (TG ≥ 150 mg/dl, ≥ 1.7 mmol/L), (3) reduced
HDL cholesterol (HDL < 50 mg/dl or < 1.29 mmol/L in
women), (4) elevated blood pressure (BP ≥ 130/85
mmHg), and (5) elevated fasting plasma glucose (FPG ≥
110 mg/dl or ≥ 6.1 mmol/L) or pre-existing diabetes
mellitus (DM).
In addition to the NCEP ATP III [8] definition, we
have used International Diabetes Federation (IDF) [9]
and NCEP ATP III criteria modified for Asian subjects
(WC ≥ 80 cm in women) as recommended by an Amer-
ican Heart Association-National Heart Lung Blood Insti-
tute (AHA/NHLBI) statement [10]. The modified NCEP
ATP III criteria were the same as those of the IDF cri-
teria except that the waist circumference criterion was
non-obligatory.
Socioeconomic status and variables
Socioeconomic status (SES) has been identified as an
important determinant of health across a broad range of
health issues [11,12]. SES is a multidimensional con-
struct that includes education, occupation, income,
wealth, and residence. However, the measure of this
construct in less-developed countries creates a challenge
because adequate data may not be available. Therefore,
inclusion of several measures of SES is advantageous
because it increases the likelihood of capturing a
broader and, subsequently, more informative SES con-
structs [12]. No previous studies of MS have explicitly
examined the effect of modifying SES in the Bangladeshi
context. We sought to determine whether selected SES
indicator variables modify the association between var-
ious measures of MS among 1535 rural Bangladeshi
women.
We considered education, family income, land owner-
ship and living housing area as indicators of SES follow-
ing Argos et al. [12] and Durkin et al. [13]. The baseline
questionnaire measured years of education, family
income, land ownership and living housing area for all
participants.
Statistical analysis
The statistical analysis was carried out using Statistical
Package for Social Sciences (SPSS Inc., Chicago, IL, ver-
sion 18.0 for Windows). All quantitative variables were
estimated using measures of central location (mean,
median) and measures of dispersion (standard deviation
and standard error). Proportions were compared using
Chi square test. Logistic regression analysis was applied
to find out independent predictors for MS. All statistical
tests were two-sided and performed at a significance
level of p = 0.05.
Results
The present study is, to date, one of the largest commu-
nity-based and comprehensive MS surveys done on
rural Bangladeshi women. A total of 1,535 females aged
between 15 and 85 years were included for analysis in
the present study (mean ± SE age of 40.50 ± 0.35 years).
Women aged 35 to 54 represented about half of the par-
ticipants; whereas elderly women aged 65 and above
represented only 5.15% (Figure 1A). The age-wise distri-
bution of subjects were 13.49% (< 25 years), 19.74% (25-
34 years), 24.69% (35-44 years), 25.08% (45-54 years),
11.86% (55-64 years) and 5.15% (65 years+) (Figure 1A).
Prevalence of metabolic syndrome
The prevalence rates of MS based on the three different
criteria were 25.60% (NCEP ATP III), 36.68% (modified
NCEP ATP III) and 19.80% (IDF criteria) (Figure 1B).
Note that analysis using modified NCEP ATP III,
showed a consistently higher prevalence of the MS com-
pared to the other two criteria, namely NECP ATP III,
and IDF (Figure 1B).
Demographic and clinical profile of subjects
According to the NCEP ATP III criteria, the highest
prevalence of MS in rural Bangladeshi women was
43.96% for the age group between 55 to 64 years (Figure
1C). The incidence of MS was found to increase with
age, e.g., 2.90% of those below 25 years had MS com-
pared to 43.96% for the age group between 55 to 64
years (Figure 1C). However, due perhaps to the poor
response by the 65 years + age group, the prevalence of
MS in this age group was found to be lower than the
age group between 55 to 64 years, a group that had the
highest prevalence. Numbers of MS components
increase with advancement in age; particularly two and
three components for this population were observed to
increase (Figure 2). Among the subjects, 4.56% females
had no components of MS, while 0.78% females had all
5 components of MS.
Age classified MS characteristics shows that mean sys-
tolic and diastolic blood pressure, in rural Bangladeshi
women were increasing with the advancement of age;
mean cholesterol and fasting blood glucose appeared to
increase till age group 45-54(Table 1). BMI was statisti-
cally significant for the age group 35-44 and age ≥ 65
compared to the age group < 25. WC was statistically
significant for almost all age groups compared to the
group age < 25; SBP and DBP were also statistically sig-
nificant for all age groups compared to the group age <
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Figure 1 (A) Age distribution of study subjects (n = 1535), (B) Prevalence of metabolic syndrome of Bangladeshi rural women based
on three established criteria (NECP ATP III, Modified NECP ATP III, IDF), (C) Age stratified prevalence of metabolic syndrome of
Bangladeshi rural women (NCEP ATP III criteria).
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Page 4 of 1125. Age dependent increase was significant for LDL for
45-54 age group compared to the group age < 25. The
mean fasting blood glucose has been shown to be signif-
icant for 35-44, 45-54, 55-64 and ≥ 65 age groups com-
p a r e dt ot h eg r o u pa g e<2 5 .M e a nt r i g l y c e r i d ea n d
cholesterol levels were significant for 45-54 and 55-64
age groups compared to the group age < 25. However,
there was no statistically significant age-dependency for
HDL cholesterol increase.
Table 2 shows the various socio-demographic and
clinical parameters that have been compared between
respondents with and without MS (as per NCEP ATP
III criteria). We found a significant difference in MS
prevalence by SES indicators. MS is more common
among the respondents in higher socioeconomic status
(SES) than lower SES. Higher prevalence was found
among the respondents with higher family income, land
ownership and larger housing space (MS vs. non-MS:
family income ≥ 140 USD 5.9% vs. 2.7%, family income
70-139 USD 20.9% vs. 15.6%, family income < 70 USD
73.3% vs. 77.8%, p = 0.071; family having land 70.5% vs.
51.8%, family having no land 27.2% vs. 43.1%, p =<
0.001; family living area > 1,000 sq. ft. 83.5% vs. 70.4%,
family living area ≤ 1,000 sq. ft. 16.5% vs. 29.6%, p =<
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Figure 2 Age stratified prevalence of metabolic syndrome (MS) components of Bangladeshi rural women (NCEP ATP III criteria, n =
1535). (0 = no MS component present, 1 = one component of MS present,2 = two components MS present, 3 = three components MS
present, 4 = four components MS present, 5 = five components MS present).
Table 1 Characteristics of respondents by age and MS components
Age < 25 25-34 35-44 45-54 55-64 Age ≥ 65 Total
BMI (kg/m
2) 20.11 ± 0.26 21.26 ± 0.23 21.76 ± 0.22* 21.18 ± 0.21 21.12 ± 0.43 22.25 ± 0.61* 21.26 ± 0.11
Waist circumference (cm) 72.95 ± 0.62 77.95 ± 0.54* 79.02 ± 0.49* 77.53 ± 0.49* 77.44 ± 0.88* 74.54 ± 0.9 77.35 ± 0.25
Systolic BP (mmHg) 98.47 ± 0.98 106.18 ± 0.89* 115.36 ± 1.02* 122.09 ± 1.3* 132.35 ± 2.23* 136.29 ± 3.07* 115.62 ± 0.62
Diastolic BP (mmHg) 67.56 ± 0.69 71.35 ± 0.53* 75.61 ± 0.51* 77.48 ± 0.59* 81.74 ± 1.05* 84.14 ± 1.52* 75.16 ± 0.3
Cholesterol (mg/dL) 153.87 ± 5.51 166.58 ± 3.82 170.29 ± 3.48 189.37 ± 4.05* 187.09 ± 5.71* 168.17 ± 8.61 173.88 ± 1.89
LDL cholesterol (mg/dL) 97.09 ± 5.23 111.16 ± 3.61 110.46 ± 3.24 125.9 ± 3.85* 120.95 ± 5.44 110.92 ± 7.61 113.92 ± 1.77
HDL cholesterol (mg/dL) 33.64 ± 0.79 34.32 ± 0.67 34.87 ± 0.56 33.54 ± 0.64 33.7 ± 1.01 34.26 ± 1.71 34.13 ± 0.31
TG (mg/dL) 102.9 ± 5.95 93.59 ± 3.69 117.8 ± 4.52 139.02 ± 5.65* 150.66 ± 8.99* 115.32 ± 11.24 119.31 ± 2.44
Fasting blood glucose (mmol/L) 5.06 ± 0.06 5.39 ± 0.09 6.14 ± 0.15* 6.79 ± 0.2* 6.65 ± 0.31* 7.07 ± 0.36* 6.1 ± 0.08
Values are represented as Mean ± SE; Significance level, * P < 0.05
Jesmin et al. BMC Public Health 2012, 12:49
http://www.biomedcentral.com/1471-2458/12/49
Page 5 of 110.001). Educated respondents without MS were more
compared to those with MS (MS vs. non-MS: having
formal education 43.5% vs. 50.6%, having no education
56.5% vs. 49.4%, p = 0.017). Parental history of diabetes
mellitus (DM) and hypertension were significantly more
among those with MS than in non-MS group (MS vs.
non-MS: parental history of DM 18.1% vs. 9.0%, p <
0.001; parental history of hypertension 23.2% vs. 15%, p
= 0.003). However, tobacco use was not significant
between MS group and non-MS group, it is rather con-
trasted. Current tobacco users constituted 18.8% among
MS and 21.7% among non-MS.
Prevalence of individual components of metabolic
syndrome
Based on the original NCEP ATP III criteria, the most
common risk factor of MS observed (Table 3) in the
present study was low levels of serum HDL cholesterol,
i.e., observed in 85.47% of the target population. This
was immediately followed by high fasting blood glucose
levels (30.42% of the target population), high blood pres-
sure (29.12% of the target population) and elevated
serum triglyceride levels (26.91% of the target popula-
tion). Waist circumference levels ≥ 88 cm were found in
11.6% of individuals. When waist circumference cut-offs
were reduced based on the modified NCEP ATP III cri-
teria, low HDL was again found to be the most common
risk factor followed by elevated fasting plasma glucose
level and hypertension (Table 3). It is interesting to note
the sharp rise in the prevalence of central obesity, when
the cut-off for waist circumference is lowered to 80 cm
in women (11.6% to 31.01%).
Prevalence of individual risk factors of MS that match
different age groups (as per NCEP ATP III) is given in
Table 3. Highest prevalence of waist circumference (≥
88 cm) was observed among individuals aged between
35 to 44 years (15.83%). Growing prevalence of TG ≥
150 mg/dl was observed with advancing of age, with a
Table 2 Socioeconomic status of study subjects corresponding to metabolic syndrome
Parameters Subjects without MS (%) n = 1142 Subjects with MS (%) n = 393 p value
Family Income 0.071
Income < 70 USD 888 (77.8%) 288 (73.3%)
Income 70-139 USD 178 (15.6%) 82 (20.9%)
Income ≥ 140 USD 31 (2.7%) 23 (5.9%)
Missing 45 (3.9%) 0 (0%)
Own Land < 0.001
No Land 492 (43.1%) 107 (27.2%)
Land 591 (51.8%) 277 (70.5%)
Missing 59 (5.2%) 9 (2.3%)
Living Area < 0.001
Living Area ≤ 1,000 Sqr. ft 338 (29.6%) 65 (16.5%)
Living Area > 1,000 Sqr. ft 804 (70.4%) 328 (83.5%)
Education Level 0.017
No Formal Education 564 (49.4%) 222 (56.5%)
Formal Education 578 (50.6%) 171 (43.5%)
Types of Work 0.002
Desk Work 28 (2.5%) 20 (5.1%)
Physical Work 1060 (92.8%) 365 (92.9%)
Missing 54 (4.7%) 8 (2.0%)
Family History* of Diabetes < 0.001
Non Diabetic 992 (86.9%) 322 (81.9%)
Diabetic 103 (9.0%) 71 (18.1%)
Missing 47 (4.1%) 0 (0%)
Family History* of Hypertension 0.003
Non Hypertensive 924 (80.9%) 302 (76.8%)
Hypertensive 171 (15.0%) 91 (23.2%)
Missing 47 (4.1%) 0 (0%)
Smoking Habit 0.242
No 894 (78.3%) 319 (81.2%)
Yes 248 (21.7%) 74 (18.8%)
*Family history is only accounted from father and mother only
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Page 6 of 11difference noted in individuals aged ≥ 65 years. How-
ever, some younger people (< 25 years) were also found
t oh a v eav e r yh i g hp r e v a l e n c eo fl o wH D L<5 0m g / d l .
T h ep r e v a l e n c eo fh y p e r t e n s i o n( S B P≥ 130 mmHg or
DBP ≥ 85 mmHg) and elevated fasting blood glucose ≥
6.1 mmol/L increase with the advancement of age
(Table 3).
Risk factors for metabolic syndrome
Multivariate logistic regression analysis was used to eval-
uate the potential role of age, history of diabetes in par-
ents and history of hypertension in parents in
developing MS (Table 4). Advancing age emerged as
one of the most significant risk factors for developing
MS. Subjects in the age group 55-64 years had an odds
ratio (OR) of 19.07 (CI 7.97-45.65, p < 0.001) as com-
pared to those age between 15 to 24 years. Diabetes in
any one of the parents (OR 2.33, CI 1.62-3.33, p <
0.001) was also significant independent risk factor for
developing MS but hypertension in any one of the par-
ents was not significant (OR 1.35, CI 0.99-1.84, p =
0.059).
Discussion
The present study reports the first comprehensive MS
epidemiological study that evaluated 1535 women of dif-
ferent age groups from rural Bangladesh. Based on three
different criteria, the prevalence of MS was found to be
25.60% (NCEP ATP III), 36.68% (modified NCEP ATP
III), and 19.80% (IDF criteria), respectively. We found a
prevalence of MS that was highly age-dependent, i.e.,
there was an approximate four-fold increase in preva-
lence between age group 25-34 years to age group 55-64
years.
The prevalence of the MS in rural Bangladeshi women
(36.68%), as revealed here, is similar to that reported in
rural women of India (36.4%) using the NCEP ATP III
criteria with ethnic specific cut off value for waist cir-
cumference [14]. Prevalence of MS was higher (36.68%
vs. 25.60%) when ethnicity specific cut-offs for waist cir-
cumference were applied. Several population studies
have reported an increase in the prevalence of the MS
with age, regardless of definition [15-34], with some not-
ing a peak in the seventh decade and then a decline in
both sexes [15,22,26,34] or only in men
Table 3 Age stratified prevalence of individual components of metabolic syndrome
Age
Group
Obesity Waist
≥ 88 cm**
Obesity
Waist ≥ 80
cm*
High TG ≥
150 mg/dl
Low HDL <
50 mg/dl
Fasting blood
glucose ≥ 6.1 mmol/
L**
Fasting blood
glucose ≥ 5.6
mmol/L*
Hypertension (SBP ≥ 130
mmHg or DBP ≥ 85 mmHg)
Age <
25
2.90 14.98 14.01 91.79 7.73 18.36 1.93
25-34 14.19 40.26 17.49 87.13 16.17 29.04 6.60
35-44 15.83 41.16 25.59 88.92 29.55 47.23 24.01
45-54 11.69 29.61 35.32 84.94 43.38 56.88 42.86
55-64 12.09 24.18 43.96 78.02 41.76 59.89 59.89
Age >
=6 5
2.53 11.39 22.78 65.82 59.49 68.35 73.42
All
age
11.60 31.01 26.91 85.47 30.42 44.76 29.12
Values are expressed in percentage
* for Modified NCEP ATP III and IDF criteria
** for NCEP ATP III criteria
Table 4 Multivariate logistic regression analysis for risk factors for metabolic syndrome (MS)
Risk factors for MS Odds ratio (OR) 95% confidence interval for OR Significance, p
Age groups (in years) Reference group-age 15-24 years
25-34 3.25 1.33-7.95 0.010
35-44 7.39 3.15-17.37 < 0.001
45-54 15.16 6.51-35.29 < 0.001
55-64 19.07 7.97-45.65 < 0.001
> 64 16.58 6.44-42.67 < 0.001
Family history of DM Reference group-neither father or mother had DM
Father or mother had DM 2.33 1.62-3.33 < 0.001
Family history of HTN Reference group-neither father or mother had HTN
Father or mother had HTN 1.35 0.99-1.84 0.059
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Page 7 of 11[16,17,21,25,29,33]. In the present study, the prevalence
of MS increased with age but a slight decline as noted
after the age of 65 years, consistent with findings
reported in India [35]. The prevalence of MS was the
lowest in the age group below 25 years (2.90%), while it
progressively increased with age, plateauing between 55
to 64 years (43.96%). These findings indicate that aging
m a yb ear i s kf a c t o rf o rM Sf o rB a n g l a d e s h ir u r a l
women.
In the present study, based on the original NCEP ATP
III criteria, low serum HDL levels was found to be the
most common risk factor of MS, .i.e., it was observed in
85% of the target population. It is important to note
that mean HDL levels were also found to be lower than
the normal range even in the non-metabolic group
(Non-MS vs. MS; 42.48 ± 1.05, 37.03 ± 1.47). When
WC cut-offs specific for Asians were used as baseline
for analysis, low HDL again emerged as the most com-
mon risk factor of MS followed by elevated plasma glu-
cose level and hypertension. This observation in the
pattern of profile MS in the present study is consistent
with reports of previous studies performed in India
[21,36]. These Indian studies actually demonstrate a sig-
nificantly higher prevalence of low HDL cholesterol in
Indian women (90.2%) as compared to US women
(39.3%). In the present study, a consistently high preva-
lence (> 80-90%) of low HDL was observed across gen-
erations, i.e., from young to old. This observation in our
target population is critical considering that epidemiolo-
gical studies have established a strong inverse associa-
tion between HDL concentrations with increased risk of
coronary artery disease. For every mg/dl decrease in
HDL, the risk for CAD increases by 2-3% [37]. However,
the causality of this relationship is hard to prove [38].
Low HDL can be either monogenic or purely environ-
mental or, in most cases is multifactorial/polygenic in
origin [39]. HDL levels are under considerable genetic
control with heritability estimates of up to 80% [40].
Besides, the high prevalence of low HDLC even in many
individuals without obesity and hypertriglycemia, sug-
gests an ethnic predisposition to this type of dyslipide-
mia. Reports of disproportionately high prevalence of
low HDLC in South and Middle East Asia have been
accumulating recently [41]. Gupta et al. suggested that
this could be due to a high prevalence of hypoalphalipo-
proteinemia in the Indian population and needs to be
confirmed in larger prospective studies [21]. Prevalence
of high TG and low HDL-C might contribute to the
high prevalence rate of MS in this study population.
Metabolism and the genes associated with HDL and TG
are reported, at least in part, to be linked to each other
[42]. Further analysis is needed to explore the influence
of life style, food pattern or physical activity of Bangla-
deshi rural women on such type of dyslipidemia.
The prevalence of many of the components of MS has
been found to be increased over age in the present
s t u d y .T h ep r e v a l e n c eo fe l e vated fasting blood glucose
and hypertension increased with age in rural Banglade-
shi women. The overall prevalence of hypertension in
this target population was 29.43%. This hypertensive
rate is higher than previously reported, i.e., prevalence
of 18.2% [43]. The higher prevalence of elevated BP in
our subjects may be attributed to their higher intake of
saturated fat and high calorie foods. Prevalence of high
blood level of TG increased, peaking between 55 to 64
years. However, in the case of HDL level there was no
age-specific prevalence. These patterns in prevalence, as
revealed by the present study, were similar to those in a
cross-sectional population survey in urban Asian Indian
adults reported by [44]. Consistent to other reports [35],
we also found an age-dependent increase in the preva-
lence of elevated fasting plasma glucose level. Thus
from the present findings, we state that age might be a
strong risk factor for the high prevalence of many of the
components of MS in Bangladeshi rural women
although the most common prevalent component (low
level of HDL) did not shown any age-specific distribu-
tion pattern.
In the present study, elevated waist circumference is
the least frequent component of MS in rural Banglade-
shi women based on the ATP III criteria. The average
waist circumference in this population was found to be
74.80 cm, which is consistent with another study of
rural Bangladeshi women which reported a waist cir-
cumference of 68 cm [43]. Based on these findings, we
speculate that many Bangladeshis women are metaboli-
cally obese but physically non-obese. In the present
study, even when we re-evaluated our data using the
modified Asian waist circumference cut-off, we still
found that 18.05% of our participants did not have cen-
tral obesity, even though they still had MS. Another
point noteworthy is that both urban males and females
had significantly higher WC and WHR (waist hip ratio)
compared with their rural counter-parts, according to
an Indian study by Das. This means that urban dwellers
have a significantly higher central adiposity compared
with rural dwellers [14]. We do not know whether there
is a similar pattern in Bangladesh. We currently have an
ongoing study assessing the profile of MS in Bangladeshi
urban female population.
In our study, MS was significantly more prevalent
among upper SES compared to lower SES which indi-
cates SES as an emerging risk factor of MS in develop-
ing countries like Bangladesh and this finding is
consistent with a study by Deepa et al., the prevalence
of MS among persons belonging to middle income
group was significantly higher compared to those from
lower income group (18.7% vs. 6.5%) [45]. But it should
Jesmin et al. BMC Public Health 2012, 12:49
http://www.biomedcentral.com/1471-2458/12/49
Page 8 of 11be noted that the percentage of upper SES people were
few in the present study population.
Few studies have demonstrated not only increased
prevalence of diabetes but also other cardio metabolic
risk factors including glucose intolerance and insulin
resistance [46], central obesity, abnormal triglyceride
and HDL among offspring of diabetic parents [47]. In
our study, those with history of diabetes in either or
both parents had significantly increased risk of having
metabolic syndrome and other cardio metabolic risk fac-
tors including central obesity, abnormal triglyceride and
HDL. Also, those whose both parents were diabetic
were significantly more at risk than if only one of their
parents had diabetes, thus showing evidence for genetic
predisposition for developing metabolic syndrome and
cardio metabolic risk factors. Similar result has been
observed in a study done in 321 adolescent Indians [48].
In that study, the study subjects whose both parents had
diabetes had significantly more prevalence of cardio
metabolic risk factors as compared to those whose par-
ents did not have diabetes. Thus genetic factors may
play a potential role for MS development in Bangladeshi
population.
The present report complements earlier MS reports
performed in Bangladesh [7,49]. The study by Rahim
was also conducted in a rural community, but in the
outskirts of Dhaka city. The criteria they used to assess
the prevalence of MS were modified ATP vs. IDF vs.
WHO and their findings based on these criteria were
25.1% vs. 15.7 vs. 9.2%, respectively. The figures
obtained in their study were lower compared to the pre-
sent study. Discrepancies in such studies are a common.
For instance, the prevalence of MS in different parts of
India varied from 11% to 41% [5,36,50]. The underlying
causes for the observed differences between studies
within the same region and country may be attributed
to various factors, includ i n gt h et y p eo fc r i t e r i a
employed (EGIR, ATP III and IDF), target age groups
and variation in the pattern or sets of risk factors of
MS. Bhopal’s findings that a large proportion (65%) of
women in Bangladesh had low HDL cholesterol level,
are consistent with those of the present study [51].
In the present study, as we determined the prevalence
of metabolic syndrome in Bangladeshi rural women, so
we have difficulty in including the parameter work type
(desk work type or physical work type) to our multivari-
ate logistic regression analysis model. In current investi-
gation, 45 (3.03% of total study participants) subjects
were categorized to desk work and the most of the sub-
jects fell into physical work categories (1345, 93.27% of
total study participants) and some missing cases (55
subjects, 3.7% of total subjects). More intensive investi-
gation is warranted in future in this respect. Through a
cross sectional study design it is not possible to make a
concrete interpretation at this regard.
The present manuscript shows MS is an important
public health problem in Bangladesh although very few
studies have been done on it. The high prevalence of
MS may also have serious implications for health care
costs in rural Bangladesh. Thus, studies designed to
examine the direct medical costs associated with MS are
urgently needed.
Several steps can be taken to reduce the prevalence of
potential CVD risk factors in this population. A poten-
tial initiative for dietary modifications and enhanced
physical activity may have implications to reduce this
public health burden [52-54]. While proper management
of the individual risk factors and abnormalities of MS
can reduce morbidity and mortality, a more integrated
strategy will provide a better outcome. Implementation
of the strategies cited here will require a community
outreach. Thus, education and training of health care
providers is critical. It is important to ensure that health
care providers have the knowledge and skills necessary
to not only treat MS patients but organized an effective
MS prevention program to the community.
Conclusions
In conclusion, the present study reveals a high preva-
lence of MS in rural Bangladeshi women, with low
serum HDL levels as the most common risk factor.
These findings should prove useful in the formulation of
health policies and prevention programs.
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